Cargando…

Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer

BACKGROUND AND OBJECT: Polyelectrolyte microcapsule is a promising candidate for multifunctional drug delivery system. However, the lack of reports about animal experiments have greatly slowed down their development for drug delivery. We engineered biodegradable chitosan–alginate polyelectrolyte mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Haijun, Li, Fang, Wang, Dongxia, Yang, Zhihan, Yao, Chunfang, Ye, Yang, Wang, Xiaona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914552/
https://www.ncbi.nlm.nih.gov/pubmed/29719378
http://dx.doi.org/10.2147/DDDT.S158001
_version_ 1783316715480809472
author Shen, Haijun
Li, Fang
Wang, Dongxia
Yang, Zhihan
Yao, Chunfang
Ye, Yang
Wang, Xiaona
author_facet Shen, Haijun
Li, Fang
Wang, Dongxia
Yang, Zhihan
Yao, Chunfang
Ye, Yang
Wang, Xiaona
author_sort Shen, Haijun
collection PubMed
description BACKGROUND AND OBJECT: Polyelectrolyte microcapsule is a promising candidate for multifunctional drug delivery system. However, the lack of reports about animal experiments have greatly slowed down their development for drug delivery. We engineered biodegradable chitosan–alginate polyelectrolyte multilayer capsule filled with bovine serum albumin gel (BSA-gel-capsule). Herein, we demonstrated their applicability for local chemotherapy, a means of treating local or regional malignancies by direct administration of anti-tumor agents to tumor sites. METHOD: Doxorubicin (DOX) was loaded in BSA-gel-capsules and DOX-resistant cell line (MCF-7/ADR cells) was employed for antitumor studies in vitro. The cytotoxicity, cellular uptake and distribution of DOX from BSA-gel-capsules were studied. Afterwards, MCF-7/ADR xenografts tumor model was established in nude mice. The in vivo antitumor efficacy of DOX-loaded BSA-gel-capsules by intratumor injection was then evaluated. RESULT: Compared with free DOX, more effective cytotoxicity against MCF-7/ADR cells after treatment with DOX-loaded BSA-gel-capsules was revealed, demonstrating the positive reversal effect on drug-resistance. Thereafter, the more cellular uptake and nucleus distribution of DOX from BSA-gel-capsules in MCF-7/ADR cells provided convincing explanation for the reversal effect. DOX-loaded BSA-gel-capsules displayed remarkably more antitumor efficacy than free DOX in MCF-7/ADR cell-xenografted mice. Finally, the high DOX accumulation and prolonged retention in tumor site after local administration of DOX-loaded BSA-gel-capsules was demonstrated, displaying the unique advantages of BSA-gel-capsules for local chemotherapy. CONCLUSION: These findings indicate that DOX-loaded BSA-gel-capsules should be considered a potential candidate for the treatment of drug-resistant breast cancer. This paper provides a feasibility for the local chemotherapy of polyelectrolyte microcapsules, which will be a big step towards their application as drug delivery vehicles.
format Online
Article
Text
id pubmed-5914552
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59145522018-05-01 Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer Shen, Haijun Li, Fang Wang, Dongxia Yang, Zhihan Yao, Chunfang Ye, Yang Wang, Xiaona Drug Des Devel Ther Original Research BACKGROUND AND OBJECT: Polyelectrolyte microcapsule is a promising candidate for multifunctional drug delivery system. However, the lack of reports about animal experiments have greatly slowed down their development for drug delivery. We engineered biodegradable chitosan–alginate polyelectrolyte multilayer capsule filled with bovine serum albumin gel (BSA-gel-capsule). Herein, we demonstrated their applicability for local chemotherapy, a means of treating local or regional malignancies by direct administration of anti-tumor agents to tumor sites. METHOD: Doxorubicin (DOX) was loaded in BSA-gel-capsules and DOX-resistant cell line (MCF-7/ADR cells) was employed for antitumor studies in vitro. The cytotoxicity, cellular uptake and distribution of DOX from BSA-gel-capsules were studied. Afterwards, MCF-7/ADR xenografts tumor model was established in nude mice. The in vivo antitumor efficacy of DOX-loaded BSA-gel-capsules by intratumor injection was then evaluated. RESULT: Compared with free DOX, more effective cytotoxicity against MCF-7/ADR cells after treatment with DOX-loaded BSA-gel-capsules was revealed, demonstrating the positive reversal effect on drug-resistance. Thereafter, the more cellular uptake and nucleus distribution of DOX from BSA-gel-capsules in MCF-7/ADR cells provided convincing explanation for the reversal effect. DOX-loaded BSA-gel-capsules displayed remarkably more antitumor efficacy than free DOX in MCF-7/ADR cell-xenografted mice. Finally, the high DOX accumulation and prolonged retention in tumor site after local administration of DOX-loaded BSA-gel-capsules was demonstrated, displaying the unique advantages of BSA-gel-capsules for local chemotherapy. CONCLUSION: These findings indicate that DOX-loaded BSA-gel-capsules should be considered a potential candidate for the treatment of drug-resistant breast cancer. This paper provides a feasibility for the local chemotherapy of polyelectrolyte microcapsules, which will be a big step towards their application as drug delivery vehicles. Dove Medical Press 2018-04-19 /pmc/articles/PMC5914552/ /pubmed/29719378 http://dx.doi.org/10.2147/DDDT.S158001 Text en © 2018 Shen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Shen, Haijun
Li, Fang
Wang, Dongxia
Yang, Zhihan
Yao, Chunfang
Ye, Yang
Wang, Xiaona
Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer
title Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer
title_full Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer
title_fullStr Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer
title_full_unstemmed Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer
title_short Chitosan–alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer
title_sort chitosan–alginate bsa-gel-capsules for local chemotherapy against drug-resistant breast cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914552/
https://www.ncbi.nlm.nih.gov/pubmed/29719378
http://dx.doi.org/10.2147/DDDT.S158001
work_keys_str_mv AT shenhaijun chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer
AT lifang chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer
AT wangdongxia chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer
AT yangzhihan chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer
AT yaochunfang chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer
AT yeyang chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer
AT wangxiaona chitosanalginatebsagelcapsulesforlocalchemotherapyagainstdrugresistantbreastcancer